Physicians Weigh in on Key Policies to Prevent Opioid Misuse
A national survey of physicians found strong support for key policies that could help prevent opioid misuse, but report encountering barriers.
A national survey of physicians found strong support for improving prescription drug monitoring programs (PDMPs) as one way to help prevent opioid misuse.
Having lost 30,000 lives due to abuse of prescription opioids and heroin, the American Medical Association (AMA) surveyed physicians nationwide for their opinion on the opioid epidemic and how the issue can be resolved.
Other policies to end the epidemic that had strong support from respondents included increasing physician education and removing obstacles to effective care. Of the physicians surveyed, 87% agree that PDMPs offer insights into the patient’s medical history, 68% have taken continuing medical education (CME) on safe opioid prescription, 55% have taken CME on pain management with opioid alternatives, and 80% said that naloxone should be readily available to patients.
The survey also showed that many physicians actively seek more education and that 25% said that CME was not easily accessible or did not address their needs.
“This new survey helps underscore that medical societies must be leaders in providing the best resources possible to our colleagues in every state and for every specialty, both for appropriate opioid prescribing and in urging physicians to register for and use PDMPs,” AMA President Steven J. Stack, MD,
AMA President Steven J. Stack, MD,
“If a physician is considering prescribing an opioid—whether for acute or chronic pain—we strongly encourage physicians to ensure that they are current in their knowledge and training as to when an opioid is appropriate—and when it is not,” said Dr Stack.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Insurance Coverage Improves for Same-Sex Couples, Yet Disparities Persist
September 22nd 2025
- Identifying Barriers to Colorectal Cancer Screening for People With IDD
September 22nd 2025
- Rural-Urban Disparities in Colorectal Cancer Screening Persist
September 21st 2025
- AML Survival After 3 Years in Remission Comparable With General Population
September 20th 2025